PANAGORA ASSET MANAGEMENT INC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 883677
Boston, MA
Position in REGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$109,300,950
+$27,999,906 QoQ
Shares Held
175,291
+66.6% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#76
of 1,327 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $624,607,308 across 78 Biotechnology names. REGN ranks #1 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
175,291 | $109,300,950 | |
| 2 | INCY |
Incyte Corp
|
881,889 | $99,970,937 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
664,031 | $40,080,911 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
337,461 | $39,506,559 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
490,724 | $27,878,030 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
104,935 | $25,286,186 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
1,291,182 | $24,158,015 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
572,538 | $21,304,138 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $109,300,950 | 175,291 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $81,301,044 | 105,225 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $36,806,620 | 47,685 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $43,673,197 | 77,673 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,144,500 | 2,180 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $65,292,710 | 102,948 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $73,570,867 | 103,282 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $159,958,780 | 152,162 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $179,471,780 | 170,758 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $161,655,007 | 167,955 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $136,098,061 | 154,958 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $130,393,074 | 158,444 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $112,149,723 | 156,080 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $121,116,623 | 147,403 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $94,588,781 | 131,102 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $114,322,109 | 165,956 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $99,743,138 | 168,733 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $121,806,543 | 174,403 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $109,149,390 | 172,836 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $113,172,896 | 187,007 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $90,498,002 | 162,026 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $69,702,984 | 147,320 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $65,786,054 | 136,172 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $72,986,915 | 130,385 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $82,927,364 | 132,971 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $80,811,018 | 165,498 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||